Medtronic plc — Director's Dealing 2016

Aug 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-08-01

Reporting Person: HAKAMI HOOMAN (EVP & Group President Diabetes)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-01	Ordinary Shares	A	9085	—	Acquired	46946	Direct
2016-08-01	Ordinary Shares	A	11356	—	Acquired	58302	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-01	Stock Option (Right to Buy)	$88.06	A	1136	Acquired	2026-08-01	Ordinary Shares (1136)	Direct
2016-08-01	Stock Option (Right to Buy)	$88.06	A	36339	Acquired	2026-08-01	Ordinary Shares (36339)	Direct

Footnotes

F1: The restrictions on the restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2019 equals or exceeds a 3% compound annual growth rate, as determined by the Compensation Committee.

F2: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F3: This balance increased by 1,059 shares due to exempt transactions such as dividend reinvestment

F4: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.